Specific Keynote: Genome Copy Number Abnormalities in Ovarian Cancer
- 1 January 2003
- journal article
- review article
- Published by Elsevier in Gynecologic Oncology
- Vol. 88 (1) , S16-S21
- https://doi.org/10.1006/gyno.2002.6677
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancerOncogene, 2000
- Molecular Definition of a Small Amplification Domain within 3q26 in Tumors of Cervix, Ovary, and LungCancer Genetics and Cytogenetics, 2000
- NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomasProceedings of the National Academy of Sciences, 1999
- PIK3CA is implicated as an oncogene in ovarian cancerNature Genetics, 1999
- Expression of the zinc finger gene EVI-1 in ovarian and other cancersBritish Journal of Cancer, 1996
- Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomasInternational Journal of Cancer, 1995
- Molecular Cloning of Differentially Expressed Genes in Human Epithelial Ovarian CancerGynecologic Oncology, 1994
- Spectrum of Mutation and Frequency of Allelic Deletion of the p53 Gene in Ovarian CancerJNCI Journal of the National Cancer Institute, 1993
- c-myc amplification in ovarian cancerGynecologic Oncology, 1990
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989